Kosuke Kashiwabara
-
- Lung Cancer Treatments and Mutations 19
- Lung Cancer Diagnosis and Treatment 9
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Pleural and Pulmonary Diseases 4
-
- Lung Cancer Research Studies 12
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 2
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
Kosuke Kashiwabara
34 papers receiving 332 citations
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 245
- Microbiology 5
- Oncology 111
- Ophthalmology 15
- Health, Toxicology and Mutagenesis 21
Countries citing papers authored by Kosuke Kashiwabara
This map shows the geographic impact of Kosuke Kashiwabara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Kashiwabara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Kashiwabara more than expected).
Fields of papers citing papers by Kosuke Kashiwabara
This network shows the impact of papers produced by Kosuke Kashiwabara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Kashiwabara. The network helps show where Kosuke Kashiwabara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kosuke Kashiwabara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 0 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 8 | |
| 6 | 2020 | 4 | |
| 7 | 2019 | 8 | |
| 8 | 2019 | 4 | |
| 9 | 2019 | 30 | |
| 10 | 2018 | 10 | |
| 11 | 2018 | 1 | |
| 12 | 2018 | 1 | |
| 13 | 2017 | 24 | |
| 14 | 2016 | 5 | |
| 15 | Difference in benefit of chemotherapy between small cell lung cancer patients with interstitial pneumonia and patients with non-small cell lung cancer. | 2015 | 15 |
| 16 | 2015 | 3 | |
| 17 | 2011 | 9 | |
| 18 | 2002 | 1 | |
| 19 | 2002 | 25 | |
| 20 | 2002 | 22 |
About Kosuke Kashiwabara
Kosuke Kashiwabara is a scholar working on Microbiology, Pulmonary and Respiratory Medicine and Oncology, having authored 36 papers that have together received 340 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (12 papers), Lung Cancer Diagnosis and Treatment (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Pleural and Pulmonary Diseases (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (245 citations), Microbiology (5 citations) and Oncology (111 citations). Kosuke Kashiwabara has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Shinji Fujii, Shinsuke Tsumura, Hiroshi Semba, Hirotsugu Kohrogi, Kosuke Ota, Kazuhiko Fujii, Kazuhiko Sakamoto, Sho Saeki, Makoto Tanaka and Yusuke Tomita. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.